Xin Song1,2, Zhongmei Luo2,3, Haiyan Sun2,3, Lingna Hao1,2. 1. Specialty of Geriatric Endocrinology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. 2. Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China. 3. Geriatric ICU, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Abstract
BACKGROUND: There are many studies on diagnostic imaging of thyroid nodules, among which radionuclide scanning imaging has been proven to be very effective in identifying malignant lesions of thyroid nodules and is now widely used in the clinical detection of thyroid nodules. METHODS: Studies on radionuclide imaging in the diagnosis of thyroid nodules were searched in multiple Chinese and English databases, including PubMed, Web of Science, Embase, and The Cochrane Library as of July 1, 2021. The search terms included "clinical experiment", "thyroid nodule", "radionuclide imaging", "thyroid mass", "thyroid masses", "postoperative pathology", and "histopathology". The basic information and evaluation indicators in the literature were screened and extracted. Subsequently, meta-analysis was performed using RevMan 5.3 and Stata 13 software provided by the Cochrane system. In addition, forest plots and summary receiver operating characteristic (SROC) curves were drawn. RESULTS: Seven randomized controlled trails (RCTs) were included in this study. The radionuclide imaging of thyroid nodule showed the area under SROC curve of 0.38. The combined diagnostic sensitivity and specificity were 0.66 [95% confidence interval (CI): 0.46, 0.89] and 0.36 (95% CI: 0.21, 0.59), respectively. The combined positive likelihood ratio (LR) and negative LR were 0.66 (95% CI: 0.53, 0.87) and 0.67 (95% CI: 0.43, 0.95), respectively. In addition, the combined diagnostic odds ratio (OR) was 4.45 (95% CI: 0.25, 10.57). DISCUSSION: In this study, meta-analysis was used to confirm the application value of radionuclide imaging in the diagnosis of thyroid nodules. In the future, the value of radionuclide imaging in the diagnosis of thyroid nodules should be compared with other imaging detection methods. 2021 Gland Surgery. All rights reserved.
BACKGROUND: There are many studies on diagnostic imaging of thyroid nodules, among which radionuclide scanning imaging has been proven to be very effective in identifying malignant lesions of thyroid nodules and is now widely used in the clinical detection of thyroid nodules. METHODS: Studies on radionuclide imaging in the diagnosis of thyroid nodules were searched in multiple Chinese and English databases, including PubMed, Web of Science, Embase, and The Cochrane Library as of July 1, 2021. The search terms included "clinical experiment", "thyroid nodule", "radionuclide imaging", "thyroid mass", "thyroid masses", "postoperative pathology", and "histopathology". The basic information and evaluation indicators in the literature were screened and extracted. Subsequently, meta-analysis was performed using RevMan 5.3 and Stata 13 software provided by the Cochrane system. In addition, forest plots and summary receiver operating characteristic (SROC) curves were drawn. RESULTS: Seven randomized controlled trails (RCTs) were included in this study. The radionuclide imaging of thyroid nodule showed the area under SROC curve of 0.38. The combined diagnostic sensitivity and specificity were 0.66 [95% confidence interval (CI): 0.46, 0.89] and 0.36 (95% CI: 0.21, 0.59), respectively. The combined positive likelihood ratio (LR) and negative LR were 0.66 (95% CI: 0.53, 0.87) and 0.67 (95% CI: 0.43, 0.95), respectively. In addition, the combined diagnostic odds ratio (OR) was 4.45 (95% CI: 0.25, 10.57). DISCUSSION: In this study, meta-analysis was used to confirm the application value of radionuclide imaging in the diagnosis of thyroid nodules. In the future, the value of radionuclide imaging in the diagnosis of thyroid nodules should be compared with other imaging detection methods. 2021 Gland Surgery. All rights reserved.
Authors: Alexis Vrachimis; Lars Stegger; Christian Wenning; Benjamin Noto; Matthias Christian Burg; Julia Renate Konnert; Thomas Allkemper; Walter Heindel; Burkhard Riemann; Michael Schäfers; Matthias Weckesser Journal: Eur J Nucl Med Mol Imaging Date: 2016-04-08 Impact factor: 9.236
Authors: Lilian Yuri Itaya Yamaga; Marcelo L Cunha; Guilherme C Campos Neto; Marcio R T Garcia; Ji H Yang; Cleber P Camacho; Jairo Wagner; Marcelo B G Funari Journal: Eur J Nucl Med Mol Imaging Date: 2017-04-20 Impact factor: 9.236
Authors: M Friedrich-Rust; C Vorlaender; C F Dietrich; W Kratzer; W Blank; A Schuler; N Broja; X W Cui; E Herrmann; J Bojunga Journal: Ultraschall Med Date: 2016-04-12 Impact factor: 6.548
Authors: N Muñoz Pérez; J M Villar del Moral; M A Muros Fuentes; M López de la Torre; J I Arcelus Martínez; P Becerra Massare; D Esteva Martínez; M Cañadas Garre; E Coll Del Rey; P Bueno Laraño; J A Ferrón Orihuela Journal: Langenbecks Arch Surg Date: 2013-04-28 Impact factor: 3.445
Authors: Desiree Deandreis; Abir Al Ghuzlan; Anne Auperin; Philippe Vielh; Bernard Caillou; Linda Chami; Jean Lumbroso; Jean Paul Travagli; Dana Hartl; Eric Baudin; Martin Schlumberger; Sophie Leboulleux Journal: Thyroid Date: 2012-01-18 Impact factor: 6.568
Authors: Laura I Wharry; Kelly L McCoy; Michael T Stang; Michaele J Armstrong; Shane O LeBeau; Mitch E Tublin; Biatta Sholosh; Ari Silbermann; N Paul Ohori; Yuri E Nikiforov; Steven P Hodak; Sally E Carty; Linwah Yip Journal: World J Surg Date: 2014-03 Impact factor: 3.352
Authors: Caitlin Agrawal; Lory Guthrie; Mollie S Sturm; Joseph Stanek; Laura Martin; Maria Henwood-Finley; Jennifer H Aldrink; Randal Olshefski; Sarah H O'Brien Journal: J Pediatr Hematol Oncol Date: 2016-01 Impact factor: 1.289